Volcano Corporation, based in San Diego, California, is a medical technology company that specializes in developing and manufacturing precision-guided medical devices to diagnose and treat coronary and peripheral artery diseases. The company was founded in 2000 by a group of cardiologists who aimed to revolutionize intravascular ultrasound (IVUS) technology. Volcano Corporation's headquarters are located in San Diego, which serves as the center for research, development, manufacturing, and global operations.

The company operates internationally, with subsidiaries and offices in Europe, Asia, and Latin America. Notable subsidiaries include Axsun Technologies, Inc., which provides advanced photonic components, and Crux Biomedical Inc., specializing in advanced thrombectomy technology. The company's main products include its intravascular imaging and functional measurement devices, which utilize technologies such as IVUS, fractional flow reserve (FFR), and optical coherence tomography (OCT).

These devices are used by cardiologists and endovascular specialists to visualize and measure arterial structures, guide interventions, and optimize patient outcomes. Volcano Corporation has a strong global market presence, with its products being used in leading hospitals and clinics across the globe. The company has established partnerships and joint ventures with major medical technology companies to further enhance its market reach.

Notable partners include Philips Healthcare, Boston Scientific Corporation, and Medtronic Inc. In terms of market position, Volcano Corporation has positioned itself as a leader in the field of intravascular imaging and functional measurement. The company's innovative technologies and precision-guided devices have gained significant recognition, making Volcano Corporation a preferred choice among healthcare professionals worldwide.

With strong global sales and a focus on research and development, the company continues to drive growth and maintain a competitive edge in the industry. Over the years, Volcano Corporation has achieved several milestones and received recognition for its innovations. In 2014, the company announced a major breakthrough with its Instant Wave-Free Ratio (iFR) technology, offering a quicker and easier alternative to FFR measurements.

Volcano Corporation has also expanded its product lineup through acquisitions and partnerships, strategically broadening its offerings and further establishing its position in the global market. As of the latest available information, Volcano Corporation was acquired by Royal Philips in 2015. The acquisition further strengthened Philips' position in the image-guided therapy market and allowed Volcano Corporation to leverage Philips' global resources for continued expansion and innovation.

Since the acquisition, the company has continued to thrive under the Philips brand, with ongoing development and advancements in precision-guided medical devices. In conclusion, Volcano Corporation is a renowned medical technology company based in the United States, specializing in precision-guided medical devices for diagnosing and treating coronary and peripheral artery diseases. With a strong global presence, strategic partnerships, and a focus on technological innovation, the company has established itself as a leader in intravascular imaging and functional measurement.

While operating under the Philips brand following its acquisition in 2015, Volcano Corporation continues to develop advanced medical devices to improve patient outcomes worldwide